Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes M Ludwig

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|June 12, 2016
Reply to: "Percutaneous Management of Benign Biliary Strictures: Is It Time to Focus on Reducing Procedure Invasiveness?"Johannes M Ludwig, Stuart J Knechtle, Hyun S Kim
Oncotarget|April 19, 2017
Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasisMeaghan S Dendy, Johannes M Ludwig, Hyun S Kim
European Radiology|August 27, 2016
Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus <sup>90</sup>Y-radioembolization for hepatocellular carcinomaJohannes M Ludwig, Di Zhang, Minzhi Xing, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Oligometastatic Disease and Interventional Oncology: Rationale and Research DirectionsNikitha Murali, Johannes M Ludwig, Nariman Nezami, et al.
Surgical Oncology|August 16, 2017
Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic reviewOlaguoke Akinwande, Meaghan Dendy, Johannes M Ludwig, et al.
Radiology|May 9, 2018
Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population StudyMinzhi Xing, Nima Kokabi, Di Zhang, et al.
Liver Cancer|November 27, 2019
Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future DirectionsMeaghan S Dendy, Johannes M Ludwig, Stacey M Stein, et al.
Journal of Clinical Gastroenterology|June 16, 2017
Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population StudyFelix Nautsch, Johannes M Ludwig, Minzhi Xing, et al.
Diagnostics (Basel, Switzerland)|February 9, 2016
The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersJohannes M Ludwig, Juan C Camacho, Nima Kokabi, et al.
Cancer Medicine|August 21, 2019
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver diseaseCortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Vascular and Interventional Radiology : JVIR|June 12, 2016
Reply to: "Percutaneous Management of Benign Biliary Strictures: Is It Time to Focus on Reducing Procedure Invasiveness?"Johannes M Ludwig, Stuart J Knechtle, Hyun S Kim
Oncotarget|April 19, 2017
Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasisMeaghan S Dendy, Johannes M Ludwig, Hyun S Kim
European Radiology|August 27, 2016
Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus <sup>90</sup>Y-radioembolization for hepatocellular carcinomaJohannes M Ludwig, Di Zhang, Minzhi Xing, et al.
Cancer Journal (Sudbury, Mass.)|March 25, 2020
Oligometastatic Disease and Interventional Oncology: Rationale and Research DirectionsNikitha Murali, Johannes M Ludwig, Nariman Nezami, et al.
Surgical Oncology|August 16, 2017
Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic reviewOlaguoke Akinwande, Meaghan Dendy, Johannes M Ludwig, et al.
Radiology|May 9, 2018
Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population StudyMinzhi Xing, Nima Kokabi, Di Zhang, et al.
Liver Cancer|November 27, 2019
Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future DirectionsMeaghan S Dendy, Johannes M Ludwig, Stacey M Stein, et al.
Journal of Clinical Gastroenterology|June 16, 2017
Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population StudyFelix Nautsch, Johannes M Ludwig, Minzhi Xing, et al.
Diagnostics (Basel, Switzerland)|February 9, 2016
The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersJohannes M Ludwig, Juan C Camacho, Nima Kokabi, et al.
Cancer Medicine|August 21, 2019
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver diseaseCortlandt M Sellers, Johannes Uhlig, Johannes M Ludwig, et al.
Pageof 5